Logo del repository
  1. Home
 
Opzioni

Low-dose sirolimus in two cousins with autoimmune lymphoproliferative syndrome-associated infection

Nocerino A.
•
Valencic E.
•
Loganes C.
altro
Tommasini A.
2018
  • journal article

Periodico
PEDIATRICS INTERNATIONAL
Abstract
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by non-malignant lymphoproliferation and autoimmunity, with a wide spectrum of clinical manifestations (OMIM 601859). Typical features include enlarged spleen and lymph nodes and autoimmune cytopenia. We describe a family with ALPS in which two cousins independently presented to their physicians with infection and discuss the therapeutic potential of sirolimus.
DOI
10.1111/ped.13494
WOS
WOS:000428458700025
Archivio
http://hdl.handle.net/11368/2964579
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85042432577
https://onlinelibrary.wiley.com/doi/full/10.1111/ped.13494
Diritti
open access
license:copyright editore
license:digital rights management non definito
FVG url
https://arts.units.it/request-item?handle=11368/2964579
Soggetti
  • adenoidal hypertrophy...

  • autoimmune lymphoprol...

  • infection

  • recurrent otitis medi...

  • sirolimu

  • Anti-Bacterial Agent

  • Autoimmune Lymphoprol...

  • Child

  • Child, Preschool

  • Dose-Response Relatio...

  • Female

  • Human

  • Immunosuppressive Age...

  • Infant

  • Male

  • Otitis Media

  • Pneumonia, Bacterial

  • Sirolimus

Web of Science© citazioni
6
Data di acquisizione
Mar 27, 2024
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback